When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...

Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

New research warns that popular deep learning systems trained for cancer pathology may be relying on hidden shortcuts rather than genuine biological signals.

But it is not abstract art: it is Artificial Intelligence in medicine, which is already making a difference in cancer prevention in Charleston. The system, called Genius, is the first to win approval ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...

This repository contains a MATLAB-based image processing project focused on leaf segmentation and morphometric analysis. The work was completed as part of the MOD002643 – Image Processing module at ...

Exercise can slow tumour growth in mice by shifting the body’s metabolism so that muscle cells, rather than cancer cells, take the glucose and grow. A similar process may occur in people. To examine ...

Please provide your email address to receive an email when new articles are posted on . Patients are increasingly using AI to diagnose their dermatologic conditions and triage malignant lesions.

Abstract: For this project, in the need of a standardized method to process and analyze images obtained from a technique to evaluate cell migration during cancer research, an image processing software ...

This is a retrospective review of patients at a single US center who died with cancer between 2018 and 2022, and had documented GOC notes in the last 12 months of life. Eight GOC components were ...